News Column

ACETO CORP FILES (8-K/A) Disclosing Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits

July 10, 2014

Item 2.01. Completion of Acquisition or Disposition of Assets.



On April 30, 2014, Rising Pharmaceuticals, Inc., a wholly owned subsidiary of Aceto Corporation ("Aceto"), acquired 100% of the issued and outstanding membership interests of PACK Pharmaceuticals, LLC ("PACK"). PACK, a national marketer and distributor of generic prescription and over-the-counter pharmaceutical products, has headquarters in Buffalo Grove, Illinois, a suburb of Chicago. The purchase price was approximately $91,596,000 which was comprised of the issuance of 259,814 shares of Aceto common stock, valued at $5,685,000 and a cash payment of approximately $85,911,000. The purchase agreement also provides for a three-year earn-out of up to $15,000,000 in cash based on the achievement of certain performance-based targets.

On May 2, 2014, Aceto Corporation filed a Current Report on Form 8-K stating that it completed the acquisition of 100% of the membership interests of PACK and that the financial statements and pro forma financial information required under Item 9.01 of Form 8-K would be filed within the time period specified in the instructions to Item 9.01 of Form 8-K. This amended Current Report on Form 8-K contains the required financial statements and pro forma financial information.

Item 9.01. Financial Statements and Exhibits.



(a) Financial Statements of Business Acquired.

The audited financial statements of PACK Pharmaceuticals, LLC, for the fiscal year ended December 31, 2013 are attached hereto as Exhibit 99.1.

(b) Pro Forma Financial Information.

The unaudited pro forma financial information for Aceto, after giving effect to the acquisition of 100% of the membership interests of PACK and adjustments described in such pro forma financial information, are attached hereto as Exhibit 99.2.

Exhibit No. Description



23.1 Consent of Plante & Moran, PLLC.

99.1 Audited financial statements of PACK Pharmaceuticals, LLC for the fiscal year ended December 31, 2013. 99.2 Unaudited pro forma financial information for Aceto, after giving effect to the acquisition of 100% of the membership interests of PACK and adjustments described in such pro forma financial information. 2


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Edgar Glimpses


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters